October 20, 2011
Pfizer Inc. agreed to pay $14.5 million to resolve claims brought by two ex-employee whistleblowers that it used kickbacks and deceptive marketing to convince Medicaid providers to prescribe a bladder control drug for off-label purposes, plaintiffs' attorneys said Thursday.